Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C54H90N6O18 |
Molecular Weight | 1111.3239 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)[C@]1([H])C(=O)O[C@@]([H])(C)C(=N[C@@]([H])(C(C)C)C(=O)O[C@]([H])(C(C)C)C(=N[C@]([H])(C(C)C)C(=O)O[C@@]([H])(C)C(=N[C@@]([H])(C(C)C)C(=O)O[C@]([H])(C(C)C)C(=N[C@]([H])(C(C)C)C(=O)O[C@@]([H])(C)C(=N[C@@]([H])(C(C)C)C(=O)O[C@]([H])(C(C)C)C(=N1)O)O)O)O)O)O
InChI
InChIKey=FCFNRCROJUBPLU-DNDCDFAISA-N
InChI=1S/C54H90N6O18/c1-22(2)34-49(67)73-31(19)43(61)55-38(26(9)10)53(71)77-41(29(15)16)47(65)59-36(24(5)6)51(69)75-33(21)45(63)57-39(27(11)12)54(72)78-42(30(17)18)48(66)60-35(23(3)4)50(68)74-32(20)44(62)56-37(25(7)8)52(70)76-40(28(13)14)46(64)58-34/h22-42H,1-21H3,(H,55,61)(H,56,62)(H,57,63)(H,58,64)(H,59,65)(H,60,66)/t31-,32-,33-,34+,35+,36+,37-,38-,39-,40+,41+,42+/m0/s1
Molecular Formula | C54H90N6O18 |
Molecular Weight | 1111.3239 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 12 / 12 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Valinomycin is an ionophore and acts by creating an influx of K+ ions in bacterial cells. It is an antibiotic substance with wide range of activity against different bacteria, fungies and virus-infected cells. Also it demonstrates insecticide and nematocide properties. Because of its toxicity to eukaryotic cells, valinomycin cannot be used in human therapy.
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Participation of hyf-encoded hydrogenase 4 in molecular hydrogen release coupled with proton-potassium exchange in Escherichia coli. | 2001 |
|
Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4. | 2001 Dec |
|
On-chip integration of sequential ion-sensing system based on intermittent reagent pumping and formation of two-layer flow. | 2001 Nov 15 |
|
BCL-2 does not control programmed cell death in the IPLB-LdFB cell line from the insect Lymantria dispar. | 2002 |
|
Profiling of drugs for membrane activity using liposomes as an in vitro model system. | 2002 |
|
ATP generation during reduced inorganic sulfur compound oxidation by Acidithiobacillus caldus is exclusively due to electron transport phosphorylation. | 2002 Apr |
|
Reconstitution of coupled fumarate respiration in liposomes by incorporating the electron transport enzymes isolated from Wolinella succinogenes. | 2002 Apr |
|
Effects of the ionophores valinomycin, ionomycin and gramicidin A on the element compartmentation in cultured rat hepatocytes. | 2002 Apr |
|
Valinomycin sensitivity proves that light-induced thylakoid voltages result in millisecond phase of chlorophyll fluorescence transients. | 2002 Apr 22 |
|
Potassium-selective atomic force microscopy on ion-releasing substrates and living cells. | 2002 Aug 15 |
|
Acetylcholine leads to free radical production dependent on K(ATP) channels, G(i) proteins, phosphatidylinositol 3-kinase and tyrosine kinase. | 2002 Aug 15 |
|
Photodynamic activation of ion transport through lipid membranes and its correlation with an increased dielectric constant of the membrane. | 2002 Aug 19 |
|
Calcium uptake and calcium transporter expression by trophoblast cells from human term placenta. | 2002 Aug 31 |
|
Stimulation of voltage-dependent calcium channels during capacitation and by progesterone in human sperm. | 2002 Dec 15 |
|
Phosphatidylserine content is a more important contributor than transmembrane potential to interactions of merocyanine 540 with lipid bilayers. | 2002 Dec 23 |
|
N-terminal domain of the dual-targeted pea glutathione reductase signal peptide controls organellar targeting efficiency. | 2002 Dec 6 |
|
Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation. | 2002 Feb |
|
Determinants of the phagosomal pH in neutrophils. | 2002 Feb 22 |
|
Conditions that may affect the results of susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. | 2002 Jan |
|
Regulation of intracellular pH in Calu-3 human airway cells. | 2002 Jan 15 |
|
Anacardic acid-mediated changes in membrane potential and pH gradient across liposomal membranes. | 2002 Jan 2 |
|
Mitochondrial sequestration and Ca(2+)-dependent release of cytosolic Zn(2+) loads in cortical neurons. | 2002 Jul |
|
Roles of the Na,K-ATPase alpha4 isoform and the Na+/H+ exchanger in sperm motility. | 2002 Jul |
|
Evaluation of the separate equilibrium processes that dictate the upper detection limit of neutral ionophore-based potentiometric sensors. | 2002 Jul 1 |
|
Efflux of chromate by Pseudomonas aeruginosa cells expressing the ChrA protein. | 2002 Jul 2 |
|
The fetal and neonatal brain protein neuronatin protects PC12 cells against certain types of toxic insult. | 2002 Jun 30 |
|
Evidence for a gamma-hydroxybutyrate (GHB) uptake by rat brain synaptic vesicles. | 2002 Mar |
|
Interference of MI-D, a new mesoionic compound, on artificial and native membranes. | 2002 Mar |
|
Ca(2+) influx through the osteoclastic plasma membrane ryanodine receptor. | 2002 May |
|
Measuring the dielectric properties of herpes simplex virus type 1 virions with dielectrophoresis. | 2002 May 10 |
|
Permeability transition-independent release of mitochondrial cytochrome c induced by valinomycin. | 2002 Nov |
|
Artificial cell based on lipid hollow polyelectrolyte microcapsules: channel reconstruction and membrane potential measurement. | 2002 Nov 1 |
|
Improved purification for thermophilic F1F0 ATP synthase using n-dodecyl beta-D-maltoside. | 2002 Nov 1 |
|
Ferrous-iron-dependent uptake of L-glutamate by a mesophilic, mixotrophic iron-oxidizing bacterium strain OKM-9. | 2002 Oct |
|
Biochemical and biophysical properties of purified phospholipid vesicles containing bovine heart cytochrome c oxidase. | 2002 Oct |
|
Rehydration of high-density sickle erythrocytes in vitro. | 2002 Oct 15 |
|
Cyclic hexapeptide of D,L-alpha-aminoxy acids as a selective receptor for chloride ion. | 2002 Oct 23 |
|
Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. | 2002 Sep |
|
Measurement of extracellular pH, K(+), and lactate in ischemic heart. | 2002 Sep 1 |
|
Vesicle transmembrane potential is required for translocation to the cytosol of externally added FGF-1. | 2002 Sep 2 |
|
Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. | 2003 Apr |
|
Activation of Akt is essential for acetylcholine to trigger generation of oxygen free radicals. | 2003 Apr 1 |
|
Purified human MDR 1 modulates membrane potential in reconstituted proteoliposomes. | 2003 Apr 1 |
|
Active sulfate secretion by the intestine of winter flounder is through exchange for luminal chloride. | 2003 Feb |
|
Involvement of a Na+/HCO-3 cotransporter in mouse sperm capacitation. | 2003 Feb 28 |
|
Evidence for nucleotide-dependent passive H+ transport protein in the plasma membrane of barley roots. | 2003 Jan |
|
Activity of isosteviol lactone on mitochondrial metabolism. | 2003 Jun 5 |
|
Application of the empirical force field to macrocyclic ion carriers, siderophores, and biomimetic analogs. | 2003 Mar |
|
Calcium release from Synechocystis cells induced by depolarization of the plasma membrane: MscL as an outward Ca2+ channel. | 2003 May |
|
Transport of L-arginine and nitric oxide formation in human platelets. | 2003 May |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/16597209
Valinomycin is a potent replication inhibitor of severe acute respiratory syndrome (SARS) (or similar) coronavirus (CoV) infections in Vero cells with an EC50 = 0.85 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Jun 26 13:43:32 UTC 2021
by
admin
on
Sat Jun 26 13:43:32 UTC 2021
|
Record UNII |
N561YS75MN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1976
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
6423
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
PRIMARY | |||
|
D014634
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
PRIMARY | |||
|
3000706
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
PRIMARY | |||
|
2001-95-8
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
PRIMARY | |||
|
217-896-6
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
PRIMARY | |||
|
DB14057
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
PRIMARY | |||
|
M11366
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
PRIMARY | Merck Index | ||
|
C924
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
PRIMARY | |||
|
N561YS75MN
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
PRIMARY | |||
|
2001-95-8
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
PRIMARY | |||
|
VALINOMYCIN
Created by
admin on Sat Jun 26 13:43:32 UTC 2021 , Edited by admin on Sat Jun 26 13:43:32 UTC 2021
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |